Nasdaq
RNA
Atrium Therapeutics, Inc.
- Health Care
- 1 day
- +3.2%
- 1 month
- −8.5%
- 1 year
- —
$12.11 · Mkt cap $207M
At the 6 Aug 2026 close
Nasdaq
Atrium Therapeutics, Inc.
$12.11 · Mkt cap $207M
At the 6 Aug 2026 close
Atrium Therapeutics, Inc. trades under the ticker RNA on Nasdaq, in the Health Care sector (Biotechnology: Pharmaceutical Preparations). Its market capitalisation is $207M. The last closing price was $12.11, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing.
This page exists because RNA is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.